ANRO: Gunggung utang perusahaan Alto Neuroscience

Alto Neuroscience, Inc. (ANRO) develops personalized psychiatric treatments in the US utilizing AI-driven brain analysis. The leverage ratio on GURU.Markets provides real-time dynamics of liabilities, where the indicator remains around 0.03. Asset value growth is driven by breakthroughs in depression treatment and M&A potential, while the company strictly adheres to biochemical waste disposal regulations.

Alto Neuroscience, Inc. - Utang perusahaan ANRO (periode 21.02.2024 - 29.10.2026)

Rincian analitis lan laporan data perusahaan Alto Neuroscience (ANRO)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega Alto Neuroscience Corp|ANRO - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Alto Neuro|ANRO - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham Alto Neuroscience|ANRO - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih altoneuroscience.com|ANRO - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Alto Neuroscience, Inc.|ANRO - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Alto Neuroscience Inc|ANRO - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Alto Neuro|ANRO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Alto Neuroscience

Analisis wiwitan perusahaan:Alto Neuroscience Corp ANRO

This indicator aggregates all loan and bond obligations, allowing for a real-time assessment of the company's financial autonomy without reporting delays. By analyzing the business's debt dynamics, an investor can determine if Alto Neuroscience, Inc. (ANRO) possesses sufficient resources to protect its AI-psychiatry patents and compete with industry behemoths without excessive credit dependence.

Pesaing wigati